Rezultati - Leppig, Kathleen
- Showing 1 - 20 results of 48
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies od Stephens, Karen, Weaver, Molly, Leppig, Kathleen A., Maruyama, Kyoko, Emanuel, Peter D., Le Beau, Michelle M., Shannon, Kevin M.
Izdano 2006Text -
10
“It would be so much easier”: health system-led genetic risk notification—feasibility and acceptability of cascade screening in an integrated system od Henrikson, Nora B., Blasi, Paula R., Fullerton, Stephanie M., Grafton, Jane, Leppig, Kathleen A., Jarvik, Gail P., Larson, Eric B.
Izdano 2019Text -
11
Ethical conflicts in translational genetic research: lessons learned from the eMERGE-III experience od Halverson, Colin M. E., Bland, Harris T., Leppig, Kathleen A., Marasa, Maddalena, Myers, Melanie, Rasouly, Hila Milo, Wynn, Julia, Clayton, Ellen Wright
Izdano 2020Text -
12
Characteristics Associated with Participation in ENGAGED 2 – A Web-based Breast Cancer Risk Communication and Decision Support Trial od Wernli, Karen J, Bowles, Erin A, Knerr, Sarah, Leppig, Kathleen A, Ehrlich, Kelly, Gao, Hongyuan, Schwartz, Marc D, O’Neill, Suzanne C
Izdano 2020Text -
13
-
14
A web-based personalized risk communication and decision-making tool for women with dense breasts: design and methods of a randomized controlled trial within an integrated health c... od Knerr, Sarah, Wernli, Karen J., Leppig, Kathleen, Ehrlich, Kelly, Graham, Amanda L., Farrell, David, Evans, Chalanda, Luta, George, Schwartz, Marc D., O’Neill, Suzanne C.
Izdano 2017Text -
15
Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance od Patel, Harsh V., Henrikson, Nora B., Ralston, James D, Leppig, Kathleen, Scrol, Aaron, Jarvik, Gail P., DeVange, Shannon, Larson, Eric B, Hartzler, Andrea L.
Izdano 2022Text -
16
What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk? od Bowen, Deborah J, Makhnoon, Sukh, Shirts, Brian H., Fullerton, Stephanie M, Larson, Eric, Ralston, James D, Leppig, Kathleen, Crosslin, David R., Veenstra, David, Jarvik, Gail P.
Izdano 2021Text -
17
Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening od Henrikson, Nora B., Blasi, Paula, Figueroa Gray, Marlaine, Tiffany, Brooks T., Scrol, Aaron, Ralston, James D., Fullerton, Stephanie M., Lim, Catherine Y., Ewing, John, Leppig, Kathleen A.
Izdano 2021Text -
18
Genetic heterogeneity and core clinical features of NOG-related-symphalangism spectrum disorder od Carlson, Ryan J., Quesnel, Alicia, Wells, Dawson, Brownstein, Zippora, Gilony, Dror, Gulsuner, Suleyman, Leppig, Kathleen A., Avraham, Karen B., King, Mary-Claire, Walsh, Tom, Rubinstein, Jay
Izdano 2021Text -
19
-
20
Relationship between genetic knowledge and familial communication of CRC risk and intent to communicate CRCP genetic information: insights from FamilyTalk eMERGE III od Makhnoon, Sukh, Bowen, Deborah J, Shirts, Brian H, Fullerton, Stephanie M, Meischke, Hendrika W, Larson, Eric B, Ralston, James D, Leppig, Kathleen, Crosslin, David R, Veenstra, David, Jarvik, Gail P
Izdano 2020Text